Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

ms_pharma

MS Pharma ink deal for acquisition of Genepharm

April 17, 2019 Research and Development

Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. …
News

NICE recommends Akcea’s Tegsedi for rare, life-threatening progressive disease

April 17, 2019 Research and Development, Sales and Marketing Akcea, NHS, NICE, Tegsedi, UK

Akcea Therapeutics has shared the news that Tegsedi (inotersen), its antisense oligonucleotide (ASO) inhibitor of human transthyretin (TTR) production, has …
News
chinese_flag_beijing_-_img_1104

China introduces new laws to ensure steady supply of drugs

April 17, 2019 Research and Development China, National Health Commission, laws, markets, pharma, regulation

China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …
News
gsk_ulverston_plant_impression

GSK to make redundancies at plant in Stevenage

April 17, 2019 Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
News
janssen_latest_logo_on_sign

Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease

April 16, 2019 Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma

Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …
News

Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine

April 15, 2019 Research and Development, Sales and Marketing Pfizer, Streptococcus pneumoniae, Vaccine, pharma

Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC), detailing the …
News
about2medical

Medical cannabis: A green light for patients in need?

April 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Feature

Bayer VP elected to two of the firm’s executive committees

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment

Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Appointment
manabe

Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
Appointment
darren_cline

GW Pharma announce Darren Cline as company’s new Chief Commercial Officer

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GW Pharmaceuticals have announced the appointment of Darren Cline as the company’s new US Chief Commercial Officer. Cline will lead …
Appointment
merckwindow_web

FDA expands Keytruda label to include stage 3 and 4 non-small cell lung cancer

April 12, 2019 Medical Communications, Research and Development Cancer, MSD, keytruda, lung cancer, non-small cell lung cancer, pharma

MSD has revealed that its anti-PD-1 therapy Keytruda (pembrolizumab) has received expanded indication from the FDA to include the first-line …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior

This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
News
opioid_pills

Opioid crisis cost US government nearly $38 billion in lost taxes

April 11, 2019 Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue

The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …
News
trafficjamdelhi

Traffic pollution linked to four million childhood asthma cases each year

April 11, 2019 Research and Development Air pollution, NO2, Traffic, asthma, emissions, pollution, public health

Air pollution is linked to four million cases of childhood asthma each year, according to research published in The Lancet …
News
hannah_pender

Living with a rare chromosome disorder

April 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Inv Dup Del 8p, feature, patient experience, pharma

Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 …
Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026